Ephedra Tablets 50mg (Eperisone Hydrochloride)

Adult dose

Eperisone hydrochloride as 50mg orally three times a day after meals. The dosage may be adjusted based on age and symptoms.

This medication should not be used in patients with a history of allergic reactions to this drug or those with severe myasthenia gravis. Furthermore, this medication contains lactose and should not be administered to patients with lactose intolerance, galactose intolerance, hereditary lactose enzyme deficiency, or glucose-galactose malabsorption. Patients with a history of hypersensitivity to the medication or those with poor liver function should use this drug with caution, as there is a risk of liver function deterioration. Severe side effects such as shock, liver dysfunction, renal dysfunction, and anemia may occur while taking this medication, so symptoms should be carefully monitored. Various side effects such as skin rash or itching, insomnia, drowsiness, headache, gastrointestinal disturbances, urinary retention, weakness, and dizziness may occur, so if any abnormal symptoms arise, immediate consultation with a healthcare provider is necessary. Severe skin adverse reactions, such as toxic epidermal necrolysis and mucocutaneous-ocular syndrome (Stevens-Johnson syndrome), may occur; if symptoms such as fever, rash, blisters, eye redness, or stomatitis occur, the medication should be stopped immediately and treatment sought. Symptoms like weakness, instability, or drowsiness may occur, and if such symptoms arise, it may be necessary to reduce or discontinue the dosage. Additionally, drowsiness or decreased attention may occur, so it is advisable to avoid driving or operating dangerous machinery while taking this medication. This medication may have interactions causing visual disturbances when taken with other muscle relaxants, so it is essential to inform the healthcare provider about any other medications being taken. For women who are pregnant or may become pregnant, this medication should only be used if the therapeutic benefits outweigh the risks, as its safety has not been established. Nursing mothers are advised to discontinue breastfeeding while taking this medication. Safety in pediatric populations has not been adequately confirmed, so this medication should be used cautiously in children. Elderly patients may have diminished bodily functions, so special attention is needed in adjusting the dosage.

Serious side effects

Shock, increased ALT, increased AST, increased ALP, proteinuria, increased BUN, anemia, anaphylaxis, angioedema, toxic epidermal necrolysis and mucocutaneous-ocular syndrome, fever, erythema, blisters, eye redness, stomatitis.

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• limb paralysis
• body stiffness
• limb tremors
• nausea
• vomiting

This medication should be stored in a sealed container to prevent air and moisture infiltration, preferably at room temperature between 1°C and 30°C. Proper storage helps maintain the drug's efficacy and prevents degradation.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle